C-reactive protein at the interface between innate immunity and inflammation.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveBlood-borne metabolic factors in obesity exacerbate injury-induced gliosisRamadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors.Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.Consolidated and emerging inflammatory markers in coronary artery diseaseNew variants including ARG1 polymorphisms associated with C-reactive protein levels identified by genome-wide association and pathway analysis.Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitisInheritance of coronary artery disease in men: an analysis of the role of the Y chromosome.Combined detection of liver stiffness and C-reactive protein in patients with hepatitis B virus-related liver cirrhosis, with and without hepatocellular carcinoma.C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexesBinding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosisPresence of multimeric isoforms of human C-reactive protein in tissues and bloodC-reactive protein in rheumatology: biology and genetics.C-reactive protein in Crohn's disease: how informative is it?Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severityThe predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations.Distinct Fcγ receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation.Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.Scrambled eggs: Proteomic portraits and novel biomarkers of egg quality in zebrafish (Danio rerio).Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications.In vitro generation and bioactivity evaluation of C-reactive protein intermediate.Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
P2860
Q24594814-8FB12339-9908-427E-B175-B4AE78A95FDCQ28396770-8B1795B0-A98C-4131-BEF1-96304295A315Q33593051-EE5A771E-9ECA-431C-9E44-CF22E30A620BQ33684950-2470A1C3-9AF6-46EE-AF8B-E7B8252B1ABBQ35019922-2D865ADB-5CDC-489D-B43C-357E49018AAAQ35157201-E84A1C7F-3D22-4FF6-B5E6-84341F076965Q35170882-684CAD8F-17F3-4F5D-B39D-4130DB8FEE9DQ35859582-C2CF47F8-49F4-472F-948C-5FEBEF86F941Q36741122-E60BAD19-30F1-447B-8BA8-EA6150017DF5Q36983038-EEF54A69-9C8C-424A-B0B1-8203C8ECA3FFQ37338146-E60781CF-AD73-431D-93F2-F8AA6B8D7D2DQ37406470-EF0D00DD-E6CD-44ED-905B-D9E520065674Q37619574-59C85529-500F-4E83-AFD8-E2F73434961BQ37707516-1B2419A9-F95A-49DE-873F-B44A03E2365FQ37862080-3141CFF3-290E-41F1-AC12-56BF1C4781F1Q38196441-8189841C-4572-4433-88B9-55B51CFE71FBQ38612010-39F18DE4-9D80-4BDB-9833-4D019BA95C53Q39333471-7A8A438B-2C13-4FD8-A096-C6600C0DF202Q39431370-32C0A29F-6FA2-43D5-B4DB-435DB232E4B2Q40472843-8053EE41-A0BC-4A76-A9A5-EF715A5A6835Q41900633-47170605-7A13-4EEC-97EC-C823C4518FE0Q42268471-0454D386-6BEB-4939-999A-D378E16A2249Q42766032-12F49C2F-5C8C-4644-90D0-3A48330A03A6Q43837250-B7F657B0-E1B2-497C-9981-94C7DB386B50Q47143422-786B2F38-5802-4A5C-9E81-10FBDFFFEE9CQ54100256-F30E9E6D-D1ED-49AF-8257-2CB51911DA03Q55222117-DC9324F3-4294-470D-8186-3A9C9CA99732Q59132141-C2AB2735-640E-4FE2-BA5B-471340F28DD9
P2860
C-reactive protein at the interface between innate immunity and inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C-reactive protein at the interface between innate immunity and inflammation.
@en
C-reactive protein at the interface between innate immunity and inflammation.
@nl
type
label
C-reactive protein at the interface between innate immunity and inflammation.
@en
C-reactive protein at the interface between innate immunity and inflammation.
@nl
prefLabel
C-reactive protein at the interface between innate immunity and inflammation.
@en
C-reactive protein at the interface between innate immunity and inflammation.
@nl
P2093
P2860
P356
P1476
C-reactive protein at the interface between innate immunity and inflammation.
@en
P2093
Andres Peisajovich
Carolyn Mold
Lorraine Marnell
Terry W Du Clos
P2860
P304
P356
10.1586/1744666X.4.3.379
P577
2008-05-01T00:00:00Z